PEG-PCL

PEG-PCL (Poly(ethylene glycol)-b-poly(ε-caprolactone)) – Biodegradable Amphiphilic Block Copolymers for Nanoformulations and Drug Delivery

ResolveMass Laboratories Inc. offers high-purity PEG-PCL block copolymers engineered for nanoparticles, micelles, long-acting formulations, and controlled-release drug delivery systems. PEG-PCL is an amphiphilic AB or ABA block copolymer composed of hydrophilic PEG and hydrophobic PCL, enabling enhanced solubility, sustained release, and excellent biocompatibility for pharmaceutical R&D.

The slow, predictable biodegradation of PCL makes PEG-PCL particularly suitable for long-duration controlled release, depot systems, and nanoparticle formulations in complex generics and novel drug delivery projects.

Key Features & Technical Advantages
1. Amphiphilic Structure Ideal for Nanocarriers

PEG-PCL self-assembles into:

Polymeric micelles

Nanoparticles

Vesicles and hybrid nanocarriers

The hydrophobic PCL core encapsulates APIs, while PEG provides a sterically stabilizing shell.

This results in:

High drug-loading capacity

Enhanced solubility for hydrophobic APIs

Extended blood circulation

Reduced aggregation and opsonization

2. Slow, Tunable Biodegradation for Sustained Release

PCL degrades more slowly than PLA/PLGA, enabling weeks to months release durations.

We provide fully customizable:

PEG block MW: 1–20 kDa

PCL block MW: 2–150 kDa

PEG:PCL ratio optimized for your formulation needs

This tunability controls:

Release kinetics

Micelle size

Hydrophobic core stability

Degradation rate

3. High-Purity Polymers with Advanced Analytical Characterization

Each PEG-PCL polymer is rigorously characterized using:

GPC/SEC (universal calibration) for molecular weight & PDI

¹H/¹³C NMR for block length and end-group determination

FTIR for structural confirmation

MALDI-TOF or HRMS (optional) for end-group analysis

DSC/TGA for thermal properties & crystallinity evaluation

These QC elements support CMC-driven formulation development, NDA-enabling research, and ANDA complex generic studies.

Applications
✔ Nanoparticles & Polymeric Micelles for Solubility Enhancement

PEG-PCL is ideal for improving solubility and bioavailability of:

Hydrophobic oncology APIs

Immunomodulators

Lipophilic small molecules

The micelles typically fall within 20–150 nm, suitable for IV administration.

✔ Long-Acting Drug Delivery Systems

Due to the slow degradation of PCL, PEG-PCL supports:

Extended-release injectables

Implantable depots

Subcutaneous slow-releasing systems

Release periods can be engineered from weeks to several months.

✔ Biologics & Peptide Delivery

PEG-PCL enhances stability and protects sensitive molecules by creating:

Hydrophobic cores

PEG shielding for steric protection

✔ Custom Block Copolymers for Novel Delivery Platforms

We specialize in designing PEG-PCL for:

High-drug-loading nanocarriers

Dual-delivery systems

Combination formulation R&D

Polymer screening for CMC development

Why Choose ResolveMass Laboratories Inc.?
✔ Expertise in Biodegradable PEG-Based Polymers

We routinely synthesize:

PEG-PCL

mPEG-PCL

mPEG-PLA

mPEG-PLGA

PCL-PEG-PCL

Fully customized block copolymer architectures

✔ Advanced Analytical Infrastructure

Our labs feature:

Triple-detector GPC

High-field NMR

HRMS / LC-MS/MS

MALDI-TOF

FTIR, DSC, TGA

✔ Formulation-Oriented Polymer Engineering

Manufactured specifically for:

Complex generics

Nanoparticle and micelle systems

Long-acting injectable development

Novel drug delivery research

Available Grades

Research grade

High-purity formulation grade

Fully customized block-length and ratio configurations

Request Custom PEG-PCL Specifications

Our chemistry team can synthesize tailored PEG-PCL polymers with precise molecular weights, ratios, and end-group chemistry to meet your project’s formulation and CMC needs.

No products were found matching your selection.
Scroll to Top
Review Your Cart
0
Add Coupon Code
Subtotal